Inflammatory diseases at epithelial borders develop from aberrant interactions between resident cells of the tissue and invading immunocytes. Here, we unraveled basic functions of epithelial cells and immune cells and the sequence of their interactions in an inflammatory skin disease. Ubiquitous deficiency of the IkBa protein (Ikba D/D ) as well as concomitant deletion of Ikba specifically in keratinocytes and T cells (Ikba K5D/K5D lckD/lckD ) resulted in an inflammatory skin phenotype that involved the epithelial compartment and depended on the presence of lymphocytes as well as tumor necrosis factor and lymphotoxin signaling. In contrast, mice with selective ablation of Ikba in keratinocytes or lymphocytes showed inflammation limited to the dermal compartment or a normal skin phenotype, respectively. Targeted deletion of RelA from epidermal keratinocytes completely rescued the inflammatory skin phenotype of Ikba D/D mice. This finding emphasizes the important role of aberrant NF-kB activation in both keratinocytes and lymphocytes in the development of the observed inflammatory skin changes.
INTRODUCTION
The pathogenesis of inflammatory diseases at the epithelial border such as psoriasis and inflammatory bowel disease is still unexplained. In psoriasis pathogenesis, there is an intensive discussion concerning the functional role of the epithelium and inflammatory cells. Recent evidence indicates that CD4 + T cells are essential for the initiation and maintenance of the disease and that crossprimed CD8 + T cells respond to antigens derived by keratinocytes (Gudjonsson et al., 2004) . In addition, overlapping susceptibility loci associated with autoimmunity define psoriasis as a putative autoimmune disease (Bowcock and Krueger, 2005 ). Yet, data from transgenic mice, such as the rat insulin promoter-glycoprotein (RIP-GP) mice (Lang et al., 2005) , suggest that selective activation of immune cells alone is not sufficient for initiation of an autoimmune disease. These findings can be combined in a model, in which development of an autoimmune disease requires simultaneous aberrant signaling in the immune system and the target organ. Psoriasis is a disease of the skin with a prevalence of approximately 2% in Caucasian populations. Phenotyping of skin-infiltrating cells in psoriasis demonstrates the prevalence of Th1 cells (Ghoreschi et al., 2003) . Data from adoptive T cell-transfer experiments (Wrone-Smith and Nickoloff, 1996) demonstrate that injection of autologous blood-derived immunocytes, especially CD4 + T cells, into nonlesional human skin transplanted onto severe combined immunodeficient mice results in the development of psoriasis in the xenograft. Il-4 therapy of patients with psoriasis improved the disease and skewed the Th1 response into an anti-inflammatory Th2 response (Ghoreschi et al., 2003) suggesting that aberrant activation of adaptive immunity is critical for the development of psoriasis. In contrast, the high therapeutic efficacy of topical treatment with anthralin (Lawrence and Shuster, 1992), which is not known to affect T cell function, as well as genetic data (Bowcock, 2005) , which do not necessarily link psoriasis-associated gene regions to ''immune loci,'' strongly suggests that psoriasis also relies on abnormal signaling events in keratinocytes showing a hyperproliferative capacity. The data available at present can be embraced in a model in which psoriatic inflammatory skin disease depends on simultaneous abnormal signaling in both compartments, the keratinocytes and the immune cells.
The transcription factor NF-kB is a complex formed by homodimerization and heterodimerization of the NF-kB family members p50 (NF-kB1), p52 (NF-kB2), RelA (p65), RelB, and c-Rel. Stimuli that are capable of activating IkB kinase (IKK) result in serine phosphorylation, ubiquitination, and subsequent degradation of IkBa, which allows translocation of NF-kB to the nucleus (Hayden and Ghosh, 2004; Karin and Ben-Neriah, 2000; Li and Verma, 2002) . In addition to degradation of IkBa, phosphorylation of the transactivating subunit RelA is an essential regulatory step for transcriptional activity (Viatour et al., 2005) . NF-kB, most often composed of p50 and RelA, is a crucial mediator of inflammatory processes (Karin and Greten, 2005) . To determine whether NF-kB overactivation might be relevant for the induction of an inflammatory skin disease, we generated mice with conditional disruption of its cytoplasmic receptor, Ikba. We found that mice with ubiquitous deletion of Ikba developed a severe inflammatory skin phenotype that involved the epithelial compartment. Neither keratinocyte-nor T cell-specific deletion of Ikba recapitulated this phenotype. Exclusively concomitant deletion of Ikba in keratinocytes and T cells resulted in development of the inflammatory phenotype observed in mice with ubiquitous deletion. Finally, this phenotype could be rescued by additional keratinocyte-specific deletion of Rela, demonstrating the importance of the NF-kB pathway in keratinocyte-T cell crosstalk in skin inflammation.
RESULTS
Aberrant Keratinization, Microabscesses, and Infiltrating Immune Cells in the Skin of Ikba D/D Mice To study the consequences of ubiquitous activation of NF-kB for skin homeostasis, we crossed mice carrying a LoxP-site-containing (floxed) Ikba allele with DeleterCre mice (Schwenk et al., 1995) . We used this loss-offunction approach because it mimics the natural events of NF-kB activation observed after natural stimulation more closely than transgenic overexpression of NF-kB. Importantly, transgenic overexpression does not allow mimicking of the quantitative aspects of NF-kB activation and, in addition, may produce misleading results because of gene-insertion artifacts. Ikba D/D mice were born with Mendelian frequencies, and the Ikba allele was properly and ubiquitously deleted (Ikba D/D ) (Rupec et al., 2005) . Skin from newborn Ikba D/D mice was inconspicuous compared to skin from wild-type mice ( Figure S1 in the Supplemental Data available online). Three days after birth, 100% of mutant mice started to develop generalized skin inflammation, characterized by erythematous thickening and scaling. The severity of the disease increased until day 7 or 8 after birth when Ikba D/D mice died. Histological analysis of skin samples from 6-day-old Ikba D/D mice revealed epidermal hyperplasia (acanthosis), a thickened cornified layer (hyperkeratosis), foci of nucleus-containing keratinocytes (parakeratosis), loss of the granular layer (hypogranulosis), T cell infiltration, and the formation of microabscesses, all hallmarks of the epidermal changes that characterize psoriasis. Dermal blood vessels were dilated, and infiltrating mononuclear and polymorphonuclear cells accumulated in the upper dermis ( Figure 1A ). Increased Ki67 expression indicated a large number of proliferating keratinocytes in comparison with mice bearing floxed Ikba alleles (Ikba f/f mice; Figure 1B ). Immunohistochemistry with markers of keratinocyte proliferation and differentiation revealed increased expression of keratin 6 (K6) in the entire epidermis, reduction of loricrin, and broadening of the keratin 5 (K5) and keratin 10 (K10) expressing keratinocyte layers in the epidermal compartment of Ikba D/D mice ( Figure 1C ). Assessment of skin permeability with the toluidine blue and acidic X-Gal staining showed no increase in dye penetration in Ikba D/D mice, suggesting no disturbance of the ''outside-in'' epidermal barrier ( Figure S2 ). All these findings seem to be a direct consequence of Ikba deletion in Ikba D/D mice because RelA and p50 containing NF-kB dimers were constitutively active in primary keratinocytes ( Figures 1D and 1E ). In addition, CD54, a typical target gene induced by NF-kB activation, was strongly expressed in the epidermis of Ikba D/D mice ( Figure 1F ). Other NF-kB regulated genes that were induced in the IkBa-deficient epidermis are Cxcl2, Ccl20, Il1b, and Mmp9, Ccl20, Ccl5 , and Il1b in the IkBa-deficient dermis ( Figure S3 ). Importantly, aberrant NF-kB activation did not result in altered in vitro proliferation of keratinocytes, indicating that the hyperproliferation observed in vivo was not cell autonomous in IkBadeficient keratinocytes ( Figure 1G ).
Epidermis-Specific Ikba Deletion Causes Selective Keratinocyte Proliferation
To analyze whether epidermis-specific activation of NFkB is sufficient for induction of the psoriasis-like skin disease, we crossed the Ikba f/f mice with keratin5-cre2 mice to generate mice with epidermis-specific deletion of Ikba (Ikba K5D/K5D ) ( Figure S4 mice was also demonstrable by phosphorylation of the transactivating subunit RelA at Ser536 ( Figure 2C ). Integrin b1 was strongly upregulated in the skin of Ikba D/D mice compared to Ikba K5D/K5D and wild-type mice ( Figure 2D ).
Importantly, the differentiation marker K6 was absent from the interfollicular epidermis of Ikba K5D/K5D mice ( Figure 2E ). Because the K6 promoter contains elements responsive to IL-1b (Komine et al., 2001 ), which plays a putative role in the pathogenesis of psoriasis, we analyzed IL-1b expression by real-time PCR. Although the keratinocyte-derived chemokines macrophage inflammatory protein-2 (MIP-2) and the keratinocyte-derived chemokine (KC) were similarly expressed in both Ikba D/D and Ikba
mice, the K6-inducing cytokine IL-1b as well as IFN-g, a cytokine putatively involved in the pathogenesis of psoriasis (Austin et al., 1999; Nestle et al., 1994; Robert and Kupper, 1999) (Hennet et al., 1995) . This resulted in complete deletion of Ikba in T cells only ( Figure S6 ). Skin of 6-day-old Ikba lckD/lckD mice was normal and did not reveal any difference as compared to that of control (Ikba f/f ) mice ( Figure 3D ; Figures S7 and S8) Figures 2D, 3E , and 3F). , and control mice with a specific antibody against integrin b1. Red counterstaining shows nuclei.
Thus, although the presence of both lymphocytes and polymorphonuclear leukocytes is required for the inflammatory skin disease, loss of IkBa from immune cells alone is not sufficient for disease initiation. Together, the data strongly suggest that simultaneous IkBa deficiency in both the epidermal compartment and the immune system is needed for initiation and maintenance of this inflammatory disease of the skin.
Skin Inflammation Depends on TNF and LT Inflamed tissue is characterized by a local milieu maintained by the production of proinflammatory cytokines. Tumor necrosis factor (TNF), lymphotoxin (LT)a, and LTb are NF-kB-regulated key mediators of inflammation (Aggarwal, 2003) . Serum TNF was under a detectable amount in control mice and strongly increased in Ikba . The skin of these animals showed no signs of inflammation and had an entirely normal phenotype ( Figure 4C and Figure S10 ), demonstrating that the inflammatory disease resembling psoriasis was dependent on TNF and LT signaling. Figure S12 ). Mice with epidermis-specific deletion of Rela (Rela K5D/K5D ) were phenotypically inconspicuous.
Epidermal RelA Coordinates Epidermal-Dermal Cell Interactions
Neither skin sections from 5-day-old nor skin sections from 4-month-old RelA K5D/K5D mice showed any signs of abnormal epidermis differentiation or proliferation, when compared to Rela f/f or wild-type controls ( Figure 5A ). As a consequence, the expression pattern of skin differentiation markers was identical to that of control skin (Figure S13 Figures 5B and 5C ). These mice exhibited no differences in the expression of epidermal differentiation markers compared to wild-type mice ( Figure S13 ). Interestingly, deletion of only one Rela allele strongly improved but did not abolish the phenotype of Ikba D/D mice. Mice deficient for IkBa and heterozygous for the epidermis-specific Rela mutation, Ikba D/D Rela +/K5D , showed hyperkeratotic, scaly, and inflamed skin only at sites exposed to mechanical friction (data not shown), similarly to Koebner's phenomenon in psoriatic individuals. Thus, epidermal RelA expression was crucial for initiation and maintenance of the inflammatory skin disease in IkBa-deficient mice.
DISCUSSION
The data presented here show that simultaneous activation of NF-kB in immune cells and in keratinocytes is sufficient for the induction of a persistent skin inflammation that shares many similarities with human psoriasis. NF-kB activation by selective deletion of IkBa either in the epidermis or in immune cells alone did not give rise to the full inflammatory skin phenotype. The skin disease required concomitant IkBa deletion in keratinocytes and lymphocytes and was strictly dependent on signaling through cytokines of the TNF superfamily, a feature shared with autoimmune diseases such as psoriasis or rheumatoid arthritis. Importantly, targeted deletion of RelA in keratinocytes of double-transgenic Ikba
Rela
K5D/K5D mice prevented disease development and demonstrated that aberrant signaling through RelA within the epidermis was essential for the development of the inflammatory skin disease. Various transgenic and knockout mice have been generated that mimic aspects of inflammatory diseases at body surfaces such as the skin (Cheng et al., 1992) , IFN-g (Carroll et al., 1997) , integrins (b1, a2b1, a5b1) (Carroll et al., 1995) , Stat3 (Sano et al., 2005) , and others (Nickoloff and Wrone-Smith, 1997; Schö n, 1999). Many of these mutations directly or indirectly modulate NF-kB activity. In most models, investigations into disease mechanisms have been restricted to either the skin or the immune system. Here, we asked whether a disturbed crosstalk between keratinocytes and immunocytes is causal for the inflammatory process already at its initiation.
By evaluating contributions of various tissue compartments to disease development, we show that epidermisspecific targeting of Ikba results in keratinocyte hyperproliferation, but without inflammation in the epidermal compartment. The infiltration of the epidermis by inflammatory cells might involve integrin b1 because we found (E) Immunostaining of skin sections from 6-day-old Ikba K5D/K5D mice and Ikba f/f mice for the indicated epidermal differentiation marker (green staining).
(F and G) Induction of the indicated genes in the skin of 6-day- Cell-cycle regulation in keratinocytes seems to be independent from intrinsic RelA activity because wild-type and
Ikba
D/D keratinocytes showed identical proliferative behavior in vitro, although NFkB signaling was constitutively active in the latter. This is further supported by the normal skin phenotype of mice with epidermis-specific deletion of Rela. The discrepancy in comparison to previously published results (Zhang et al., 2004) , demonstrating hyperproliferation in RelA deficient skin, may be due to the different experimental approach.
The central role of RelA signaling in keratinocytes for disease induction was most strikingly demonstrated by 
), 6-day-old Ikba lckD/lckD mice, and control mice were stained with hematoxylin and eosin.
(E) Skin sections from 7-day-old Ikba K5D/K5D lckD/lckD and control mice were stained with hematoxylin and eosin and immunostained for the indicated epidermal differentiation marker (green staining).
(F) Skin sections from 7-day-old Ikba K5D/K5D lckD/lckD and control mice were immunostained with antibodies recognizing T cells (CD3), macrophages (F4/80), and neutrophilic granulocytes (Gr-1) (green signal). double knockout animals that have ubiquitous deletion of IkBa and epidermis-specific deletion of RelA and that showed a normal phenotype. This is in line with the observation that skin inflammation is absent in mice with specific deletion of IkBa in immune cells only (Ikba lckD/lckD , Ikba myD/myD , and Ikba FLD/FLD ) and highlights the important pathogenic role of the epithelium. By using several different approaches, we here demonstrate a functional, pathogenic cooperation that is mediated by RelA between keratinocytes and immune cells. The exact pathogenic steps that link RelA activation in keratinocytes to T cell infiltration still remain open, although production of chemotactic factors such as S100A8, S100A9, KC, and MIP-2 and increased expression of integrinb1 are likely to be of relevance. TNF blockers have recently been introduced into the treatment of inflammatory diseases such as psoriasis (Koo and Khera, 2005) . We provide genetic evidence that, in addition to TNF and TNFR1 signaling, LTs may be important mediators in the pathogenesis of psoriasis. LTa forms homotrimers with signaling through TNFR1 and TNFR2 and forms heterotrimers with LTb signaling through LTbR (Pfeffer, 2003) . Only in a triple-knockout deficient for Tnf, Lta, and Ltb was the development of the skin phenotype efficiently inhibited, whereas it was significantly attenuated in single knockouts for either Tnfrsf1a or Tnf or Lta. Our data therefore support a therapeutic approach in which LTs are inhibited in addition to TNF. Our results show that RelA activity in keratinocytes is required for initiation of the inflammatory skin phenotype after ablation of IkBa. At first glance, this may seem surprising because IKK2 deletion that causes an inhibition of NF-kB activation produces a phenotype similar to that observed in Ikba D/D mice (Pasparakis et al., 2002) . Our analyses revealed, however, that the mechanisms leading to these two skin conditions differ fundamentally in their T cell dependence. This suggests that skin homeostasis requires balanced NF-kB activity: Constitutive activation of NF-kB will lead to a T cell-dependent inflammatory skin disease, whereas inhibition of NF-kB activation results in T cell-independent skin inflammation.
In summary, we have characterized pathogenic interactions between epithelial cells covering a body surface and immune cells. We believe that this model gives novel insight into the pathogenesis of inflammatory skin diseases but could also be of relevance to inflammatory conditions of other body surfaces, such as the gut and the urinary tract. ) and with transgenic mice expressing Cre recombinase under the control of the keratinocyte-specific keratin5 promoter (Tarutani et al., 1997) (Ikba K5D/K5D ), T cell-specific lck promoter (Hennet et al., 1995) (Ikba lckD/lckD ), and neutrophil and macrophage-specific LysM promoter (Clausen et al., 1999) The genetic background was C57BL/6 for Ikba f/f , Rela
, and TNF-LTD3 mice.
PCR
Mice were genotyped by PCR (sequence available upon request); expected sizes of the PCR products are for the Ikba gene 340 bp for the floxed allele, 250 bp for the wild-type allele, and 500 bp for the deleted allele. For the Rela gene, the expected sizes are 294 bp for the floxed allele, 260 bp for the wild-type allele, and 400 bp for the deleted allele.
Histology and Immunohistochemistry
Skin samples were fixed in 4% formaldehyde for 24 hr and embedded in paraffin, and 5 mm serial sections were stained with hematoxylin and eosin (H and E). Phosphorylated RelA was detected with antiphosphop65 (Cell Signaling Technology). For frozen sections, skin samples taken from the back were snap frozen in 2-methylbutane (Merck) and embedded in OCT Tissue Tec Media (Miles). Five-micrometer sections were cut with a Cryotom (Leica), taken up in 4% PBS, and rinsed with water. Antibodies against CD31 and CD54 (R & D Systems) were used together with the biotin-streptavidin detection system (Vector Systems). ABC-system block and the Avidin-Biotin-Block (DAKO) were used when appropriate. For visualization of antibody binding, AEC (Sigma) was applied until the desired color intensity developed. After washing in H 2 O, sections were counterstained with hematoxylin and mounted with Aquatex (Merck). Staining of inflammatory and proliferating cells was performed as described previously (Pasparakis et al., 2002) . The following rat monoclonal antibodies were used on frozen sections: anti-CD3 and -CD8 (both 1:1000; Chemicon), anti-CD4 (1:50; BD Biosciences PharMingen), and Ki-67 (1:50; clone TEC-3, Dako).
Outside-In Barrier Assays
For Toluidine blue staining, newborn mice were killed, bathed in methanol for 5 min, and, after a washing step with PBS, incubated for 15 min in 0.1% Toluidine blue (Sigma). For acidic X-Gal staining, newborn mice were killed, rinsed with water, and incubated in 4 mM K 3 Fe(CN) 6 , 4 mM K 4 Fe(CN) 6 , 2 mM MgCl 2 , 1 mg/ml 5-Bromo-4-chloro-3-indolyl b-D-galactopyranoside (Sigma), and 0.1 M KH 2 PO 4 at pH 4.5, at 30 C for 6 hr.
Electrophoretic Mobility-Shift Assay and NF-kB ELISA Electrophoretic mobility shift assays were performed as described previously (Rupec et al., 2005) . The NF-kB ELISA was performed according to the instructions of the manufacturer (Active Motif).
Isolation and Culture of Mouse Keratinocytes and T Cells
Keratinocytes were isolated from the skin of newborn mice as described (Roper et al., 2001 ) and cultured in collagen type IV-coated plates in SFM keratinocyte medium (GIBCO) on feeder cells. Cells were resuspended at 1 3 10 6 per 100 ml of PBS containing 1% FCS, pretreated with Fc-block (anti-CD16/anti-CD32, PharMingen), and stained for 30 min at 4 C with the indicated mouse antibodies. Viable cells, as determined by forward and side scatter profiles, were sorted with a MoFlo Sorter (Cytomation).
Skin Grafts
We surgically transplanted skin from 6-day-old Ikba
, Ikba K5D/K5D , and control mice into the dorsal region of 7-to 8-week-old anaesthetized Rag2 À/À mice. The average size of donor grafts was 1-1.5 cm diameter. The grafts were dressed with Jelonet* gaze (Smith + Nephew) and Fixomull stretch (BSN medical) bandage. After 10-12 days, the bandages were removed. For Ikba D/D and Ikba K5D/K5D grafts, the donor origin was verified by PCR with RNA isolated from keratinocytes.
RT-PCR
Total RNA was isolated from cultured keratinocytes or from full skin by the Trizol protocol (GIBCO/BRL). Total RNA was digested with DNase I (Sigma) for removal of DNA contamination and reverse-transcribed with SuperScript II according to the manufacturer's instructions (GIBCO/BRL). PCR amplifications were performed with the primers according to standard methods. Primer sequences are available upon request.
TNF ELISA
For determination of TNF levels in murine serum, an ELISA kit (Quantikine, R & D systems) was used according to the instructions of the manufacturer.
cDNA Libraries and Processing of Microarrays cRNA preparation was performed with the Illumina TotalPrep RNA Amplification Kit (Ambion Europe) according to the manufacturer's instructions. cRNA (1.5 mg) was hybridized to Sentix Mouse-6 Expression Beadchips (Illumina) and scanned on Illumina BeadStation 5003.
For data collection and analysis, Illumina BeadStudio and dChip 1.3 software were used.
Supplemental Data
Thirteen figures are available at http://www.immunity.com/cgi/ content/full/27/2/296/DC1/.
